MR

Maheswara Reddy Arumalla

Active Director Additional Director DIN 08518109
DIN 08518109 First appointment Jul 2019 Primary industry Food And Beverages
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 1 historical roles
Total affiliations 5 Since Jul 2019
Shareholding value •••• Premium profile

About Maheswara Reddy Arumalla

Data last updated:

Maheswara Reddy Arumalla is an Additional Director at Bhimavarapu Laboratories Private Limited (since 2022), Director at Sgenesis Life Science Private Limited (since 2020) and Designated Partner at Skandana Life Sciences Llp (since 2024), and holds 1 more current directorship. The companies operate in Food And Beverages, Information Technology and Paper. The 2 current companies with reported revenue have a combined latest revenue of ₹1.01 Cr; the largest is Bhimavarapu Laboratories Private Limited at ₹98.3 Lakh (FY 2025). Earlier, Maheswara Reddy Arumalla was a Director at Hiq Pharma Labs Private Limited (2019–2023).

DIN 08518109
Primary Designation Additional Director
Industry Food And Beverages
First Appointment 25 Jul 2019
Oldest Company Age 7 yrs
Largest company Bhimavarapu Laboratories Private Limited · ₹98.3 Lakh (FY 2025)
Combined revenue ₹1.01 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director24 Dec 20222019₹98.3 Lakh (FY 2025)Active
Director05 Oct 20202020₹3 Lakh (FY 2024)Active
Designated Partner11 Nov 20242023Active
Sunblue Technologies Private Limited U72900TG2021PTC149562
Managing Director12 Mar 20212021Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Hiq Pharma Labs Private Limited U74999TG2016PTC113739
Director25 Jul 20192016₹7.2 Lakh (FY 2022)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Sgenesis Life Science Private Limited
Sunblue Technologies Private Limited
Bhimavarapu Laboratories Private Limited
Skandana Life Sciences Llp
Premium access

Shareholding and investment profile for Maheswara Reddy Arumalla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Maheswara Reddy Arumalla

Maheswara Reddy Arumalla currently holds 4 directorships: Bhimavarapu Laboratories Private Limited (Additional Director, since 24 Dec 2022, revenue ₹98.3 Lakh (FY 2025)); Sgenesis Life Science Private Limited (Director, since 05 Oct 2020, revenue ₹3 Lakh (FY 2024)); Skandana Life Sciences Llp (Designated Partner, since 11 Nov 2024); Sunblue Technologies Private Limited (Managing Director, since 12 Mar 2021).

Maheswara Reddy Arumalla was first appointed on 25 Jul 2019 as Director at Hiq Pharma Labs Private Limited. The most recent appointment on record is 11 Nov 2024 at Skandana Life Sciences Llp.

The 2 current companies of Maheswara Reddy Arumalla that report revenue have a combined latest revenue of ₹1.01 Cr: Bhimavarapu Laboratories Private Limited ₹98.3 Lakh (FY 2025); Sgenesis Life Science Private Limited ₹3 Lakh (FY 2024).

Maheswara Reddy Arumalla held 1 earlier board appointment: Hiq Pharma Labs Private Limited (Director, 25 Jul 2019 to 21 Jul 2023).

The current boards of Maheswara Reddy Arumalla's companies include Kotireddy Bhimavarapu (Bhimavarapu Laboratories Private Limited), Padma Lakshmi Jonnala (Bhimavarapu Laboratories Private Limited), Sailaja Bhimavarapu (Bhimavarapu Laboratories Private Limited), Jaya Madhuri Abbineni (Skandana Life Sciences Llp), Lakshmi Nagareddy (Skandana Life Sciences Llp), Bharat Kumar Reddy Gujavarti (Sunblue Technologies Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available